These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 16988163)
1. Infliximab in sarcoidosis: more answers or more questions? White ES Am J Respir Crit Care Med; 2006 Oct; 174(7):732-3. PubMed ID: 16988163 [No Abstract] [Full Text] [Related]
3. [TNFα blocking agents and sarcoidosis: an update]. Toussirot E; Pertuiset E Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487 [TBL] [Abstract][Full Text] [Related]
4. [Anti-TNF: beneficial or hamful for the lung?]. Tritar F; Zendah I; Ben M'rad S; Daghfous H Tunis Med; 2009 Sep; 87(9):607-9. PubMed ID: 20180383 [TBL] [Abstract][Full Text] [Related]
5. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Farnsworth NN; George SJ; Hsu S Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907 [No Abstract] [Full Text] [Related]
6. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy. Gómez-Puerta JA; Sanmartí R; Rodríguez-Cros JR; Cañete JD Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598 [No Abstract] [Full Text] [Related]
8. Comment to the article: infliximab for treating sarcoidosis patients, Portuguese experience. Morais A Rev Port Pneumol; 2011; 17(2):94-5. PubMed ID: 21477573 [No Abstract] [Full Text] [Related]
9. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES; Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744 [TBL] [Abstract][Full Text] [Related]
11. Effective co-administration of infliximab and etanercept following the failure of sequential anti-TNF agents in a patient with HLA-B27-associated arthropathy. Sheehy C; Murphy E; Barry M Rheumatology (Oxford); 2006 Oct; 45(10):1314-5. PubMed ID: 16837474 [No Abstract] [Full Text] [Related]
12. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study. Cantini F; Niccoli L; Benucci M; Chindamo D; Nannini C; Olivieri I; Padula A; Salvarani C Arthritis Rheum; 2006 Oct; 55(5):812-6. PubMed ID: 17013842 [No Abstract] [Full Text] [Related]
13. Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis. Girolomoni G; Abeni D Arch Dermatol; 2001 Jun; 137(6):784-5. PubMed ID: 11405771 [No Abstract] [Full Text] [Related]
16. Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here? Khanna D; McMahon M; Furst DE Arthritis Rheum; 2004 Apr; 50(4):1040-50. PubMed ID: 15077286 [No Abstract] [Full Text] [Related]
17. [Successful treatment with infliximab of a patient with refractory sarcoidosis]. Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311 [TBL] [Abstract][Full Text] [Related]
18. The role of tumor necrosis factor inhibitors in patients with RA. Trethewey P JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668 [No Abstract] [Full Text] [Related]
19. [TNF antagonists in therapy of rheumatoid arthritis]. Oberpichler-Schwenk H Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266 [No Abstract] [Full Text] [Related]